Over 30,000 physicians, residents, and medical students rely on AgileMD to quickly find trust information and provide the best possible care. AgileMD is designed from the ground-up for clinical settings and operates without a fixed cellular or WiFi signal.
Our user support team is available 24/7 to help answer questions: http://agilemd.com/support
Terms of Service are available here: http://agilemd.com/about/terms-of-use
• Search for trials by browsing cancer conditions or simply by entering keywords.
• Send trial information directly to your email account.
• Send a message directly to an individual trial’s study contact.
• Send a message directly to the Cancer Clincial Trials Office.
Note: This app accesses location based information. To enable maps, please go to settings > Location Services > Use wireless networks.
Each study has a unique protocol with different gender, age, health, and lifestyle requirements. Current and past medications and medical procedures may impact qualification for certain studies. Once you are completely registered, your medical history and profile will be matched with studies you qualify for.
Studies open up every day. If you have any questions, please contact one of our Customer Care Center team members at: 866-445-7033.
More on Phase 1 Clinical Trials
Phase I trials are the first stage of testing in human subjects. Normally, a small group of 20–100 healthy volunteers will be recruited. This phase is designed to assess the safety (pharmacovigilance), tolerability, pharmacokinetics, and pharmacodynamics of a drug. These trials are often conducted in a clinical trial clinic, where the subject can be observed by full-time staff. These clinical trial clinics are often run by contract research organization (CROs, in this case, Celerion) who conduct these studies on behalf of pharmaceutical companies or other research investigators. The subject who receives the drug is usually observed until several half-lives of the drug have passed.
Phase I trials also normally include dose-ranging, also called dose escalation studies, so that the best and safest dose can be found. Phase I trials most often include healthy volunteers. However, there are some circumstances when real patients are used, such as patients who have terminal cancer or HIV and the treatment is likely to make healthy individuals ill.
Volunteers are paid an inconvenience fee for their time spent in overnight stays at the clinic and/or return visits. Pay also depends on length and complexity of participation.
Celerion’s focus is on the implementation of innovative strategies to generate key data very early to enable go/no-go decisions in drug development.
In Applied Translational Medicine, Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.
With a large clinical capacity of more than 750 beds (24 in-hospital), efficient bioanalytical laboratories and experienced scientific staff, Celerion offers one of the most experienced clinical pharmacology research networks in the industry.